The table below shows Caris Life Sciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$216.17M
$216.83M
$181.40M
$120.92M
$101.62M
$100.05M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$31.32M
$21.62M
$25.05M
$23.07M
$27.64M
$24.79M
CAI annual revenue (10-K history)
Caris Life Sciences, Inc. reported annual revenue of $812.03M for fiscal year 2025. That is up 97.0% from $412.26M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
